Kindstar Globalgene Technology Inc. (Kindstar Global) reported a modest increase in its issued share base for May 2026 following the exercise of employee share options, while its authorised share capital and treasury share position remained unchanged.

Kindstar Global’s authorised share capital stayed at USD 500,000, representing 2.00 billion ordinary shares with a par value of USD 0.00025 each as of 31 May 2026.

Issued shares (excluding treasury shares) rose by 16,676 to 1.03 billion, up from 1.03 billion at end-April. Total issued shares, inclusive of treasury stock, reached 1.04 billion. Treasury shares were unchanged at 7.06 million.

The increase stemmed entirely from the exercise of 16,676 options under the company’s Pre-IPO stock incentive plans dated 2013, 2015 and 2016. These exercises generated HKD 2,926.64 in proceeds. Outstanding options under the Pre-IPO plans now stand at 2.63 million, while the Post-IPO scheme adopted on 22 June 2021 has 67.92 million shares available for future grants but no options currently outstanding.

Kindstar Global affirmed compliance with the Main Board’s minimum public-float requirement of 25 percent as at month-end.

No movements were recorded in warrants, convertibles, other share-issuance agreements or treasury shares during the period.